Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Thoracic Neoplasms
×
Nivolumab
×
Clear all
Filters
2
NCT04564157
2025-04-10
NADIM-ADJUVANT
Fundación GECP
Phase 3
Active not recruiting
210 enrolled
NCT05583188
2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4
Terminated
5 enrolled